While this can definitely help with weight loss, it could also cause food to remain in the stomach for much longer than it should, causing it to harden and become impossible to digest
If we know exactly where this money is going, then well have a better idea of whether or not the patients are saving the money or its going towards premium support, or most likely, what is happening is, profitability by the insurers and PBMs
Over time, smoother glucose regulation may reduce some of the metabolic stress associated with repeated glucose surges
A new entrant was about to change the landscape again: semaglutide , a molecule even more potent at weight reduction and glycemic control, which would further elevate the GLP-1 class including heading into oral dosage forms and unprecedented trial results
10 Conclusion GLP-1 RAs have substantially advanced pharmacological treatment for obesity, offering robust efficacy with a favorable safety profile